397 related articles for article (PubMed ID: 23945906)
1. Management of hypertension with fixed-dose triple-combination treatments.
Epstein BJ; Shah NK; Borja-Hart NL
Ther Adv Cardiovasc Dis; 2013 Oct; 7(5):246-59. PubMed ID: 23945906
[TBL] [Abstract][Full Text] [Related]
2. Hypertension management: rationale for triple therapy based on mechanisms of action.
Neutel JM; Smith DH
Cardiovasc Ther; 2013 Oct; 31(5):251-8. PubMed ID: 23121769
[TBL] [Abstract][Full Text] [Related]
3. Single-pill triple-combination therapy: an alternative to multiple-drug treatment of hypertension.
Chrysant SG
Postgrad Med; 2011 Nov; 123(6):21-31. PubMed ID: 22104451
[TBL] [Abstract][Full Text] [Related]
4. Valsartan-amlodipine-hydrochlorothiazide: the definitive fixed combination?
Barrios V; Escobar C
Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1609-18. PubMed ID: 21090936
[TBL] [Abstract][Full Text] [Related]
5. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.
Frampton JE; Scott LJ
Am J Cardiovasc Drugs; 2009; 9(5):309-30. PubMed ID: 19791840
[TBL] [Abstract][Full Text] [Related]
6. [On the way to achieve hypertension treatment goals: results of the open observational program AESCULAP (exforge--clinical safety and efficiency of using a double combination of antihypertensive drugs in patients with uncontrolled blood pressure)].
Chazova IE; Martynyuk TV
Ter Arkh; 2013; 85(9):35-45. PubMed ID: 24261228
[TBL] [Abstract][Full Text] [Related]
7. Optimizing the Management of Uncontrolled Hypertension: What do Triple Fixed-Dose Drug Combinations Add?
Thomopoulos C; Katsimagklis G; Archontakis S; Skalis G; Makris T
Curr Vasc Pharmacol; 2017; 16(1):61-65. PubMed ID: 28413969
[TBL] [Abstract][Full Text] [Related]
8. Blood pressure control with angiotensin receptor blocker-based three-drug combinations: key trials.
de la Sierra A; Barrios V
Adv Ther; 2012 May; 29(5):401-15. PubMed ID: 22610686
[TBL] [Abstract][Full Text] [Related]
9. Newer renin-angiotensin-aldosterone system blocker combinations: is there an advantage?
Lazich I; Bakris GL
Curr Opin Nephrol Hypertens; 2011 Sep; 20(5):471-5. PubMed ID: 21709549
[TBL] [Abstract][Full Text] [Related]
10. Olmesartan/amlodipine: blood pressure lowering and beyond in special populations.
Erdine S
Ther Adv Cardiovasc Dis; 2012 Feb; 6(1):31-44. PubMed ID: 22222315
[TBL] [Abstract][Full Text] [Related]
11. The single pill triple combination of aliskiren, amlodipine, and hydrochlorothiazide in the treatment of hypertension.
Huan Y; Townsend R
Expert Opin Pharmacother; 2012 Nov; 13(16):2409-15. PubMed ID: 23067322
[TBL] [Abstract][Full Text] [Related]
12. Triple Combination Therapies Based on Olmesartan: A Personalized Therapeutic Approach to Improve Blood Pressure Control.
Volpe M; Santolamazza C; Mastromarino V; Coluccia R; Battistoni A; Tocci G
High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):255-263. PubMed ID: 28608025
[TBL] [Abstract][Full Text] [Related]
13. Amlodipine/valsartan/hydrochlorothiazide: fixed-dose combination in hypertension.
Deeks ED
Am J Cardiovasc Drugs; 2009; 9(6):411-8. PubMed ID: 19929039
[TBL] [Abstract][Full Text] [Related]
14. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
Roberts ME; Epstein BJ
J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
[TBL] [Abstract][Full Text] [Related]
15. Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic.
Volpe M; Tocci G
Vasc Health Risk Manag; 2012; 8():371-80. PubMed ID: 22745561
[TBL] [Abstract][Full Text] [Related]
16. Triple combination therapy to improve blood pressure control: experience with olmesartan-amlodipine-hydrochlorothiazide therapy.
Tocci G; Paneni F; Passerini J; Volpe M
Expert Opin Pharmacother; 2012 Dec; 13(18):2687-97. PubMed ID: 23170911
[TBL] [Abstract][Full Text] [Related]
17. Which is the optimal antihypertensive combination in different diseases, a renin- angiotensin-aldosterone system inhibitor with a diuretic or with a calcium channel blocker?
Riva N; Lip GY
Curr Pharm Des; 2013; 19(21):3753-65. PubMed ID: 23286431
[TBL] [Abstract][Full Text] [Related]
18. Clinical role of direct renin inhibition in hypertension.
Taylor AA; Pool JL
Am J Ther; 2012 May; 19(3):204-10. PubMed ID: 21317620
[TBL] [Abstract][Full Text] [Related]
19. The role of fixed-dose combination therapy with drugs that target the renin-angiotensin system in the hypertension paradigm.
Schmieder RE
Clin Exp Hypertens; 2010 Jan; 32(1):35-42. PubMed ID: 20144071
[TBL] [Abstract][Full Text] [Related]
20. Thiazide-like/calcium channel blocker agents: a major combination for hypertension management.
Safar ME; Blacher J
Am J Cardiovasc Drugs; 2014 Dec; 14(6):423-32. PubMed ID: 25163857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]